Fayez Sarofim & Co’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-25,325
Closed -$1.67M 250
2017
Q1
$1.67M Sell
25,325
-2,000
-7% -$138K 0.01% 133
2016
Q4
$1.88M Sell
27,325
-344,085
-93% -$24.7M 0.01% 130
2016
Q3
$26.2M Sell
371,410
-500
-0.1% -$37.4K 0.14% 74
2016
Q2
$28.2M Sell
371,910
-1,386
-0.4% -$102K 0.15% 74
2016
Q1
$25.6M Sell
373,296
-1,163
-0.3% -$83.6K 0.15% 73
2015
Q4
$32.7M Sell
374,459
-400
-0.1% -$34.3K 0.19% 75
2015
Q3
$30.4M Hold
374,859
0.18% 76
2015
Q2
$33.3M Sell
374,859
-38
-0% -$3.32K 0.17% 73
2015
Q1
$32.5M Hold
374,897
0.16% 72
2014
Q4
$31.7M Sell
374,897
-5,258
-1% -$411K 0.15% 70
2014
Q3
$26.9M Sell
380,155
-19
-0% -$1.35K 0.13% 71
2014
Q2
$26.4M Sell
380,174
-43
-0% -$3.03K 0.12% 73
2014
Q1
$28.6M Buy
380,217
+586
+0.2% +$43.9K 0.14% 71
2013
Q4
$26.7M Buy
+379,631
New +$24.8M 0.12% 69
2013
Q2
$23.4M Buy
+379,378
New +$22.8M 0.12% 68

Other funds holding ESRX

Fayez Sarofim & Co's ESRX Position: Q2 2017 in Review

Fayez Sarofim & Co sold out of Express Scripts Holding Company (ESRX) in Q2 2017, closing a stake of 25,325 shares — an estimated $1.67M sold.

Fayez Sarofim & Co first reported a position in ESRX in Q2 2013 and held it in 15 quarters. The position peaked at $33.3M in Q2 2015. 1,046 funds tracked by Wall St. Rank hold ESRX as of Q2 2017.

  • Fayez Sarofim & Co reported no remaining Express Scripts Holding Company position as of Q2 2017 after selling out during the quarter.
  • Fayez Sarofim & Co sold 25,325 Express Scripts Holding Company shares in Q2 2017, an estimated $1.67M.
  • Fayez Sarofim & Co first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 15 quarters.
  • Fayez Sarofim & Co's Express Scripts Holding Company position peaked at $33.3M in Q2 2015.
  • 1,046 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q2 2017.

Based on Fayez Sarofim & Co's 13F filing for Q2 2017, filed 11 Aug 2017.